S8876
磺胺甲基嘧啶
ReagentPlus®, ≥99.0%
别名:
4-氨基-N-(4-甲基-2-嘧啶基)苯磺酰胺, N1-(4-甲基嘧啶-2-基)磺胺
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C11H12N4O2S
化学文摘社编号:
分子量:
264.30
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
204-866-2
Beilstein/REAXYS Number:
249133
MDL number:
Assay:
≥99.0%
Quality Level
product line
ReagentPlus®
assay
≥99.0%
SMILES string
Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1
InChI
1S/C11H12N4O2S/c1-8-6-7-13-11(14-8)15-18(16,17)10-4-2-9(12)3-5-10/h2-7H,12H2,1H3,(H,13,14,15)
InChI key
QPPBRPIAZZHUNT-UHFFFAOYSA-N
Legal Information
ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
Still not finding the right product?
Explore all of our products under 磺胺甲基嘧啶
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
A practical sulfenylation of 2,5-diketopiperazines.
K C Nicolaou et al.
Angewandte Chemie (International ed. in English), 51(3), 728-732 (2011-12-14)
Yi Li et al.
International journal of pharmaceutics, 415(1-2), 110-118 (2011-06-08)
The ability to detect and quantify polymorphism of pharmaceuticals is critically important in ensuring that the formulated product delivers the desired therapeutic properties because different polymorphic forms of a drug exhibit different solubilities, stabilities and bioavailabilities. The purpose of this
Florian M Koch et al.
Chemistry (Weinheim an der Bergstrasse, Germany), 17(13), 3679-3692 (2011-03-03)
The first catalytic asymmetric synthesis of β-sultones is reported. This development has enabled a rapid access to a number of highly enantioenriched biologically interesting sulfonyl and sulfinyl compound classes, which makes use of the inherent ring strain of the four-membered
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| S8876-50G | 04061836961121 |
| S8876-250G | 04061836961107 |
| S8876-500G | 04061836961114 |